Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Persoonlijk profiel
Speerpunten
Drug Utilisation Research and Pharmacoepidemiology, diabetes & cardiovascular treatment. Prescribing quality and indicators. Medication adherence. Shared decision making and decision support tools.
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
Attitudes towards deprescribing and patient-related factors associated with willingness to stop medication among older patients with type 2 diabetes (T2D) in Indonesia: a cross-sectional survey study
Oktora, M. P., Yuniar, C. T., Amalia, L., Abdulah, R., Hak, E. & Denig, P., 12-jan.-2023, In: BMC Geriatrics. 23, 1, 11 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand9 Downloads (Pure) -
Pharmacist-led intervention aimed at deprescribing and appropriate use of cardiometabolic medication among people with type 2 diabetes
Crutzen, S., Baas, G., Denig, P., Heringa, M. & Taxis, K., mei-2023, In: Research in Social and Administrative Pharmacy. 19, 5, 10 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand2 Downloads (Pure) -
Role of Serum Lipids, Blood Glucose and Blood Pressure in Breast Cancer Risk for Women with Type 2 Diabetes Mellitus
Zhang, F., de Bock, G. H., Denig, P., Landman, G. W., Zhang, Q. & Sidorenkov, G., 24-jan.-2023, In: Clinical epidemiology. 15, blz. 109-121 13 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand6 Downloads (Pure) -
Sex disparities in medication prescribing amongst patients with type 2 diabetes mellitus managed in primary care
Ambrož, M., Geelink, M., Smits, K. P. J., de Vries, S. T. & Denig, P., jan.-2023, In: Diabetic Medicine. 40, 1, 10 blz., e14987.Onderzoeksoutput › Academic › peer review
Open AccessBestand1 Citaat (Scopus)7 Downloads (Pure) -
Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study
Abou, J., Crutzen, S., Tromp, V., Heringa, M., Van Marum, R., Elders, P., Taxis, K., Denig, P. & Hugtenburg, J., mrt.-2022, In: Drugs & Aging. 39, 3, blz. 209-221 13 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand7 Citaten (Scopus)25 Downloads (Pure)
Activiteiten
-
Verbeteren van geneesmiddelgebruik: hoe maken we het meetbaar?
Petra Denig (Keynote speaker)
19-mei-2022Activiteit: Professional or public presentation › Professional
-
Use of a framework in explorative research
Petra Denig (Invited speaker)
6-sep.-2022Activiteit: Academic presentation › Academic
-
38th ICPE International Conference on Pharmacoepidemiology
Petra Denig (Contributor)
2022Activiteit: Organising and contributing to an event › Academic
-
International Society for Pharmacoepidemiology (ISPE) (Externe Organisatie)
Petra Denig (Chair)
sep.-2022 → …Activiteit: Membership › Academic
-
Deprescribing in de praktijk: belemmerende en bevorderende factoren bij artsen en patiënten.
Petra Denig (Invited speaker)
6-apr.-2022Activiteit: Professional or public presentation › Professional
Datasets
-
Quality assessment of pharmacotherapy in patients with chronic kidney disease in secondary care patients
Denig, P. (Contributor), University of Groningen, 1-jan.-2019
DOI: 10.34760/5f5b7d5599e14, https://doi.org/10.34760%2F5f5b7d5599e14
Dataset
-
Quality assessment of pharmacotherapy in patients with chronic kidney disease: development of indicators
Denig, P. (Contributor), University of Groningen, 1-jan.-2019
Dataset
-
GIANTT Groningen Initiative to ANalyse Type 2 diabetes Treatment
Denig, P. (Creator), Universitair Medisch Centrum Groningen / Rijksuniversiteit Groningen, 1-jan.-2007
http://www.giantt.nl en nog één link, http://www.giantt.nl/enoutline.htm (minder tonen)
Dataset
-
Gender differences in adverse drug reactions: knowledge synthesis and exploration
de Vries, S. (Contributor), Denig, P. (Contributor), Burgers, J. S. (Contributor), Kleefstra, N. (Contributor), Mol, P. G. (Contributor) & van Puijenbroek, E. (Contributor), University of Groningen, 2-aug.-2019
DOI: 10.34894/q0xnjs, https://doi.org/10.34894%2Fq0xnjs
Dataset
-
Adherence to standard-dose or low-dose statin treatment and low-density lipoprotein cholesterol response in type 2 diabetes patients
Vries ,de, D. (Contributor), Voorham, J. (Contributor), Hak, E. (Contributor) & Denig, P. (Contributor), figshare, 25-nov.-2015
DOI: 10.6084/m9.figshare.1579453.v1, https://figshare.com/articles/Adherence_to_standard_dose_or_low_dose_statin_treatment_and_low_density_lipoprotein_cholesterol_response_in_type_2_diabetes_patients/1579453/1
Dataset
Knipsels
-
Minderen en stoppen van medicatie
19/07/2021
1 Mediabijdrage
Pers / media: Activiteiten met een maatschappelijk belang › Popular
-
Interview Farma Magazine
Martina Ambroz, Sieta de Vries, Klaas Hoogenberg & Petra Denig
18/02/2021
1 item van Media-aandacht
Pers / media: Activiteiten met een maatschappelijk belang › Professional
-
Waarom pillen steeds beter werken [Dagblad van het Noorden]
Job Boven, van, Jos Kosterink & Petra Denig
07/03/2020
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
-
Deprescribing: hoe minder, hoe beter
01/11/2019
1 Mediabijdrage
Pers / media: Activiteiten met een maatschappelijk belang › Professional
-
Verschillen in bijwerkingen bij man en vrouw onder de loep
14/04/2017
1 item van Media-aandacht
Pers / media: Onderzoek › Popular
Prijzen
-
Top 10% most cited in 2021 PlosOne papers published in 2019
Denig, Petra (Recipient), 2021
Prijs: Prize › Academic
-
Among the most popular scientific papers in Drug Safety 2019
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2019
Prijs: Other distinction › Academic
-
-
Nomination of Top downloaded paper 2018-2019 in BJCP
de Vries, Sieta (Recipient), Denig, Petra (Recipient), Mol, Peter (Recipient) & van Puijenbroek, Eugène (Recipient), 30-apr.-2019
Prijs: Other distinction › Academic
-
Among the most popular scientific papers in Drug Safety 2018
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2018
Prijs: Other distinction › Academic